MYB and adrenal cortex carcinoma: Furthermore, treatment with an ATR kinase inhibitor (VX-970) induced programmed cell death in ACC cells that are MYB-positive and also significantly decreased cellular proliferation rates and inhibited ACC tumour growth, with one mouse demonstrating tumour regression.